Table 1.
iPS | ES cells | |
---|---|---|
Reported in humans | Yes | Yes |
Embryos or donor oocytes required | No | Yes |
Stemness marker expressed | Yes | Yes |
Teratomas produced | Yes | Yes |
Utility as a research tool | Allows repeated development | Allows the study of development |
Can be used as models for human diseases | Yes | Some |
Can be used in a screen to identify drugs | Yes | Yes |
Variable fates | Likely | Yes |
Develop into specific human tissues | To be shown | Yes |
Genetically match the patient | Unknown | No |
Additional information | Cells are genetically modified in current methods | Cells are allogeneic and might cause immune rejection |
Adapted from Nishikawa et al. (34). With permission from Macmillan Publishers Ltd.